A 2,833 ha site at Dawa, east of Tema. Phase 1 covers 40 ha, with approximately 400 ha planned across five phases over a 15-year period. Shared utilities, laboratories, effluent treatment, cold storage and logistics facilities would serve pharmaceutical manufacturers.
Project overview
Investment opportunity
Phase 1 capital sought is £150.1m, equivalent to US$198.7m. The full programme cost is estimated at £1.9bn, equivalent to US$2,515.6m. Anchor manufacturers and long-term financing partners are sought.
Investment types sought
Project status
Development stage
Feasibility & due diligence
Current status / progress to date
Anchor tenant specifications are needed before construction. Funding for the Centre of Excellence is being pursued separately.
Expected impact
Jobs created / supported
Centre of Excellence training capacity of 100 professionals initially and up to 500 annually as it expands.
Economic & development benefits
- Import substitution in pharmaceutical manufacturing, reducing dependence on imported medicines
- Pharmaceutical market growth from an estimated £389m in 2023 to £680m by 2030
- Cost savings of 25-30% on upfront construction and infrastructure for tenants
- Estimated Phase 1 equity IRR of 12-15%
Contact
Contact team
For more information about this project, please contact the Commonwealth Investment Platform team.